Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

NCT02221271 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Guillain-Barré Syndrome

Interventions

DRUG: NPB-01

Sponsor

Nihon Pharmaceutical Co., Ltd